Case Studies |

October 17-21, 2009 • Lisbon, Portugal
ACTIVATED COLLAGEN ACCELERATES WOUND REPAIR AND MODULATES CYTOKINE PRODUCTION IN WHOLE BLOOD AND PBMC CULTURES.
Gregory B. Pott PhD, K. Scott Beard MS, Matthew Regulski DPM and Leland Shapiro MD
|

On July 9-11, 2009 • New Orleans, Louisiana
Clincal Uses of CellerateRX by Dr. Jane Fore.
|

April 26-28, 2009 • Dallas, Texas
Cellerate was presented in two abstracts:
Emerging Use of Topical Biologics in Limb Salvage: The Role of "Activated Collagen" in the Multimodality Treatment.
CellerateRx: An Evidence Based Skin Tear Study: Interim Evaluation.
|

March 19-21, 2009 • Los Angeles, California
Cellerate was presented in an abstract titled:
Activated Collagen an Evidence Based Study (Interim Data) in Human Leg Ulcers.
|

November/December 2008
APWCA Case #1: Using Combined Treatment Modalities for Successful Wound Healing.
|

September 10-13, 2008 • New Orleans, Louisiana
Cellerate was highlighted during Dr. Gary Rothenberg's presentation titled:
Emerging Use of Topical "Biologics" in Limb Salvage: Role of "Activated Collagen" in Multimodality Treatment.
|

April 24-26, 2008 • San Diego, Callifornia
Cellerate was presented in an abstract titled:
Wound Pain Reduction with Hydrolyzed Collagen.
|

August 2008
Published in the issue of Advances in Skin & Wound Care
Activated, Type I Collagen (CellerateRx) and Its Effectiveness in Healing Recalcitrant Diabetic Wounds: A Case Presentation.
|
CellerateRX Case Study: CS02A: Arterial Wound
|
CellerateRX Case Study: CS03B: 1st and 2nd Degree Burns of the Leg and Arm
|
CellerateRX Case Study: CS04P: Stage III Pressure Ulcer
|
| CellerateRX Case Study: CS05P: Stage III Pressure Ulcer |